Head and Neck Cancer Trial, Recruiting NCT06287034 Sponsor: Regina Elena Cancer Institute Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06287034
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed (confirmed by tissue testing) with squamous cell carcinoma (a type of cancer) of the voice box (larynx) that has come back or not fully responded to treatment, where the original treatment was radiation therapy alone or radiation therapy combined with chemotherapy
  • People whose cancer was at an early-to-intermediate stage before their radiation treatment (specific staging categories — confirm with trial site)
  • People whose cancer is at a specific stage before surgery (specific restaging categories — confirm with trial site)
  • People for whom the surgical team has recommended a total laryngectomy (full surgical removal of the voice box) that does not involve removing tissue from the throat/food passage (pharyngeal mucosa)
  • People aged 18 years or older
  • People who are able to sign a consent form and complete in-clinic questionnaires

Who may not be able to join:

  • People whose planned surgery would extend to remove part of the throat (pharynx), including full removal of both the voice box and the throat
  • People whose cancer has spread into the lining of the throat (pharyngeal mucosa) or has spread extensively beyond the voice box
  • People who have previously had open voice-box preservation surgery (a specific type of surgery to try to keep the larynx — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raul Pellini, Doctor, IRCCS "Regina Elena" National Cancer Institute

Phone: 06-52664484

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Regina Elena Cancer Institute
Registry
ClinicalTrials.gov
Start date
21 March 2023
Est. completion
21 March 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

questionnaires for evaluation of the quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov